Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

49 results about "Cell death rate" patented technology

Enzymatically decomposed clam oligopeptide having recovery effect on non-alcoholic fatty liver disease cell model and preparation method of calm oligopeptide

The invention relates to an enzymatically decomposed clam oligopeptide having a recovery effect on a non-alcoholic fatty liver disease (NAFLD) cell model. The clam oligopeptide is characterized by comprising an amino acid sequence of Gln Leu Asn Trp Asp. The invention also relates to a preparation method of the enzymatically decomposed clam oligopeptide having the recovery effect on the NAFLD cell model. Compared with the prior art, the following advantages can be achieved: the NAFLD cell model is established by virtue of induction of palmitic acid and the damaged liver cells in a body are simulated sufficiently, and the result indicates that the TG content of the in-vitro NAFLD cell model established 48 hours after induction by 15 micrograms/milliliter palmitic acid increased remarkably in comparison with that of normal liver cells; oil red O staining shows that the number of intracellular lipid droplets of the model group is increased in contrast with that of the cells of a normal group, and the cell mortality rate is low and the repeatability is good, and therefore, the modeling method is simple, convenient and feasible; meanwhile, the enzymatically decomposed clam oligopeptide having the obvious recovery effect on the NAFLD cell model can be separated out from clams.
Owner:ZHEJIANG OCEAN UNIV

Method for culturing mesenchymal stem cells through manual simulation of bone marrow microenvironment

The invention relates to a method for culturing mesenchymal stem cells through manual simulation of the bone marrow microenvironment. The method comprises the following steps: acquiring the mesenchymal stem cells, and carrying out culture in vitro in a culture medium by adopting a three-dimensional cell culture scaffold, wherein the three-dimensional cell culture scaffold is made of collagen and chitosan or lysine, or the three-dimensional cell culture scaffold is made of collagen, chitosan and glutaraldehyde. According to the method, by adopting chitosan or lysine, or adopting chitosan and glutaraldehyde to modify the collagen scaffold, the mechanical property of the collagen scaffold can be improved; a three-dimensional porous structure of the three-dimensional cell culture scaffold is adopted for maintaining the three-dimensional growing environment in the in-vitro culturing process of the mesenchymal stem cells, so that the bone marrow microenvironment suitable for the growth of the mesenchymal stem cells can be well simulated, and the problem that in the prior art, the single three-dimensional cell culture scaffold is adopted for culturing the mesenchymal stem cells, the mechanical property of the scaffold is poor, so that the cell proliferation rate is low, and the cell death rate is high, is solved.
Owner:SHEN ZHEN ISTEM REGENERATIVE MEDICINE SCI TECH CO LTD

A nozzle device with wrapping function

The invention discloses a nozzle apparatus with a package function, and the nozzle apparatus not only is capable of overcoming the problem that the existing 3D biological printing technology is excessively high in cell death rate, but also can realize the uniform arrangement of biological particles. The nozzle apparatus with the package function mainly comprises a nozzle main body, a conical positioning part, a capillary pipe, a pinhead, a locking nut, a quick connector and a sealing screw. The nozzle apparatus with the package function has the characteristics that the conical positioning part is fixedly connected with the nozzle main body by virtue of threads and positioned by virtue of conicity; the capillary pipe is in clearance fit with the conical positioning part to be positioned, and the capillary pipe is fixed in an adhesion manner; the pinhead is fixed to the nozzle main body by virtue of the locking nut and positioned by virtue of the conicity at the outlet end of the nozzle main body, so that the coaxiality requirement of the capillary pipe and the pinhead is met; and two cavities are formed between the conical positioning part and the nozzle main body, an inner cavity and an outer cavity are respectively fully filled with different materials, the pressures of the inner cavity and the outer cavity are respectively controlled by virtue of a pressure feedback and control circuit, the flow rate of the biological material in the inner cavity and the outer cavity is further controlled, the package of cells or active biological materials as well as the uniform arrangement of particles are realized, and the nozzle also has the advantage of easiness in machining.
Owner:SICHUAN REVOTEK CO LTD

Cell transportation equipment

The invention relates to the technical field of transportation, in particular to cell transportation equipment. The equipment comprises a box body and a containing box, wherein the containing box is used for containing transported cells and arranged in the box body in a suspended mode. The equipment further comprises a fixing piece, wherein the fixing piece is located between the containing box and the inner wall of the box body and is fixedly arranged in the box body, and the fixing piece is provided with a through groove with a notch facing the containing box; the first damping piece is inserted into the through groove and fixedly connected with the groove top and the groove bottom of the through groove, wherein a mounting groove with a notch facing the containing box is formed in the middle of the first damping piece, and the first damping piece is used for damping the containing box; and one end of a second damping piece is detachably inserted into the mounting groove, and the other end of the second damping piece is fixedly connected with the containing box and used for damping the containing box. According to the cell transportation equipment, the problem that the death rateof the transported cells is increased due to poor shockproof performance in the transportation process of an existing cell transportation equipment can be solved.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products